Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1722 | BEAM Beam Therapeutics Inc. - Common Stock | 28.77 USD | -3.33% | +7.47% | +13.05% | +71.45% | 2.97 B USD | ||
| 1724 | IRON Disc Medicine, Inc. - Common Stock | 80.34 USD | +0.66% | +2.96% | +7.95% | +33.06% | 3.08 B USD | ||
| 1749 | ZLAB Zai Lab Limited - American Depositary Shares | 25.31 USD | -2.69% | -0.35% | +32.24% | -5.17% | 2.84 B USD | ||
| 1785 | NRIX Nurix Therapeutics, Inc. - Common stock | 26.06 USD | -2.47% | -3.12% | +8.72% | +132.47% | 2.70 B USD | ||
| 1791 | VRDN Viridian Therapeutics, Inc. - Common Stock | 24.16 USD | -0.54% | +6.15% | +23.96% | +7.62% | 2.74 B USD | ||
| 1796 | ATAI AtaiBeckley Inc. - Common Stock | 7.35 USD | -0.41% | +1.52% | +2.51% | +86.08% | 2.73 B USD | ||
| 1839 | PGEN Precigen, Inc. - Common Stock | 7.04 USD | -2.22% | +9.66% | +30.61% | +68.42% | 2.52 B USD | ||
| 1846 | TRVI Trevi Therapeutics, Inc. - Common Stock | 17.43 USD | -2.95% | -5.01% | -1.75% | +126.66% | 2.48 B USD | ||
| 1851 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.85 USD | +0.08% | -1.19% | -5.55% | -13.80% | 2.55 B USD | ||
| 1854 | NKTR Nektar Therapeutics - Common Stock | 71.62 USD | -3.24% | +0.14% | +0.87% | -2.25% | 2.45 B USD | ||
| 1876 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 9.54 USD | -0.10% | -1.55% | -1.04% | +10.93% | 2.44 B USD | ||
| 1878 | OCUL Ocular Therapeutix, Inc. - Common Stock | 10.80 USD | -2.53% | -1.64% | +25.00% | -6.09% | 2.37 B USD | ||
| 1879 | NUVB Nuvation Bio Inc. Class A Common Stock | 6.74 USD | -2.74% | +7.67% | +1.97% | +131.62% | 2.37 B USD | ||
| 1886 | KOD Kodiak Sciences Inc - Common Stock | 37.07 USD | -3.29% | -12.18% | -10.48% | +261.66% | 2.33 B USD | ||
| 1899 | PHVS Pharvaris N.V. - Ordinary Shares | 36.16 USD | -0.30% | +2.73% | +4.66% | +56.88% | 2.36 B USD | ||
| 1903 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 33.69 USD | +4.37% | +7.64% | -6.26% | +13.28% | 2.43 B USD | ||
| 1913 | URGN UroGen Pharma Ltd. - Ordinary Shares | 45.54 USD | -2.82% | -5.52% | +10.94% | +139.68% | 2.23 B USD | ||
| 1921 | MLYS Mineralys Therapeutics, Inc. - Common Stock | 25.11 USD | -2.11% | -0.83% | -7.75% | -37.80% | 2.22 B USD | ||
| 1936 | MRVI Maravai LifeSciences Holdings, Inc. - Class A common stock | 8.46 USD | -2.08% | +49.21% | +24.41% | +245.31% | 2.20 B USD | ||
| 1939 | HRMY Harmony Biosciences Holdings, Inc. - Common Stock | 38.00 USD | -0.39% | -0.76% | +6.65% | +22.98% | 2.21 B USD |
Nachrichten Biotechnology Stocks
Deutsche Bank stuft Argenx Aktie wegen Bewertung auf ’Hold’ herab
Klinischer Meilenstein ohne Kursschub: Aktie von Monte Rosa Therapeutics unter Druck
Biomea Fusion Aktie mit Kurssprung nach Abschluss der Rekrutierung für Diabetes-Studie
Monte Rosa Aktie fällt nach Start von Phase-2-Studie zu Prostatakrebs
ROUNDUP/Aktien New York: Chipwerte belasten Nasdaq kräftig - Dow leicht im Plus
Crinetics Pharmaceuticals Aktie erreicht Allzeithoch bei 84,8 USD
H.C. Wainwright bekräftigt "Buy"-Rating für Biomea Fusion nach Meilenstein in Diabetes-Studie
Gainers Biotechnology Stocks
SKYE Skye Bioscience, Inc. - Common Stock | 2.11 | +653.57% |
RCKTW Rocket Pharmaceuticals, Inc. - Warrant | 0.0038 | +280.00% |
ENGNW enGene Therapeutics Inc. - Warrants | 0.4301 | +71.90% |
NTRBW Nutriband Inc. - Warrant | 0.7500 | +50.00% |
LSTA Lisata Therapeutics, Inc. - Common Stock | 1.98 | +27.74% |
BMEA Biomea Fusion, Inc. - Common Stock | 1.68 | +22.63% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1098 | +19.09% |
ELOX Eloxx Pharmaceuticals, Inc. | 20.97 | +16.24% |
Losers Biotechnology Stocks
OABIW OmniAb, Inc. - Warrant | 0.1700 | -40.27% |
CINGW Cingulate Inc. - Warrants | 0.0060 | -34.07% |
RGNX REGENXBIO Inc. - Common Stock | 8.14 | -24.07% |
ASBPW Aspire Biopharma Holdings, Inc. - Warrant | 0.0131 | -17.09% |
ADIL Adial Pharmaceuticals, Inc - Common Stock | 5.25 | -15.59% |
APLMW Apollomics Inc. - Warrant | 0.0111 | -13.95% |
BCTX BriaCell Therapeutics Corp. - Common Shares | 3.61 | -11.30% |
YDESW YD Bio Limited - Warrants | 0.3642 | -11.17% |